Malignant mesothelioma in situ: morphologic features and clinical outcome

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma

(2018) Raghavendra Pillappa et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Malignant mesothelioma in situ

(2018) Andrew Churg et al.   HISTOPATHOLOGY

5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin

(2018) Matteo Bosio et al.   MULTIDISCIPLINARY RESPIRATORY MEDICINE

Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas

(2018) Kyra B. Berg et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

(2018) Julija Hmeljak et al.   Cancer Discovery

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

(2017) Tomoyuki Hida et al.   LUNG CANCER

BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation

(2017) Angela Bononi et al.   NATURE

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

(2016) Raphael Bueno et al.   NATURE GENETICS

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

(2013) Douglas W Henderson et al.   JOURNAL OF CLINICAL PATHOLOGY

The Separation of Benign and Malignant Mesothelial Proliferations

(2012) Andrew Churg et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Prominent In Situ Component in a Pleural Malignant Mesothelioma

(2010) Francesca Bono et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival

(2010) Alyssa M Krasinskas et al.   MODERN PATHOLOGY

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

(2008) Simion Chiosea et al.   MODERN PATHOLOGY